Aspirina Tablet
FDA Label NDC 0280-0161

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Bayer Healthcare Llc. for the product Aspirina (NDC 0280-0161). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding other, active ingredient (in each caplet)/principio activo (en cada cápsula), purposes/efectos, uses/usos, warnings/advertencias, do not use/ no lo use, ask a doctor before use if/antes de tomar este producto, consulte a su médico en los siguientes casos, ask a doctor or pharmacist before use if you are taking a prescription drug for/consulte a su médico o a un farmacéutico antes de usar este producto si actualmente está tomando un medicamento de venta con receta para, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.